FDA
-
-
-
-
-
-
-
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
-
-
-
-
-
-
-
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
-
-
-
-
-
-
-
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
-
-
-
-
-
-
-
AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
-
-
-
-
-
-
-
AVITA Medical Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
-
-
-
-
-
-
-
Avita Medical Limited (RCEL) Announces FDA Approval of RECELL GO mini
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

